Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID

키워드

참고문헌 (141)

1. "WHO coronavirus (COVID-19) dashboard"[URL]
2. Soriano JB, "A clinical case definition of post-COVID-19 condition by a Delphi consensus", Lancet Infect Dis, 22, pp.e102~e107 (2022)
3. "COVID-19 rapid guideline: managing the longterm effects of COVID-19"[URL]
4. Yelin D, "ESCMID rapid guidelines for assessment and management of long COVID", Clin Microbiol Infect, 28, pp.955~972 (2022)
5. "NIH launches new initiative to study “Long COVID”"[URL]
6. Davis HE, "Characterizing long COVID in an international cohort : 7 months of symptoms and their impact", EClinicalMedicine, 38, pp.101019~ (2021)
7. Gorna R, "Long COVID guidelines need to reflect lived experience", Lancet, 397, pp.455~457 (2021)
8. "Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021" (2021)[URL]
9. Jennings G, "A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19 : ongoing symptomatic phase vs. post-COVID-19 syndrome", J Clin Med, 10, pp.5913~ (2021)
10. Lacobucci G, "Long covid : damage to multiple organs presents in young, low risk patients", BMJ, 371, pp.m4470~ (2020)
11. Ziauddeen N, "Characteristics and impact of long Covid : findings from an online survey", PLoS One, 17, pp.e0264331~ (2022)
12. Kim Yoonjung, "Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea", Infection and Chemotherapy, 53(3), pp.463~476 (2021), 대한감염학회[DOI]
13. Kim Y, "Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea", BMC Infect Dis, 22, pp.93~ (2022)
14. 김윤정, "One Year Follow-Up of COVID-19 Related Symptoms and Patient Quality of Life: A Prospective Cohort Study", Yonsei Medical Journal, 63(6), pp.499~510 (2022), 연세대학교의과대학[DOI]
15. Michelen M, "Characterising long COVID : a living systematic review", BMJ Glob Health, 6, pp.e005427~ (2021)
16. Cabrera Martimbianco AL, "Frequency, signs and symptoms, and criteria adopted for long COVID-19 : a systematic review", Int J Clin Pract, 75, pp.e14357~ (2021)
17. Brodin P, "Immune determinants of COVID-19 disease presentation and severity", Nat Med, 27, pp.28~33 (2021)
18. Logue JK, "Sequelae in adults at 6 months after COVID-19 infection", JAMA Netw Open, 4, pp.e210830~ (2021)
19. Lund LC, "Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission : a Danish population-based cohort study", Lancet Infect Dis, 21, pp.1373~1382 (2021)
20. Ayoubkhani D, "Risk of long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19vaccine: community-based, matched cohort study", medRxiv 2022;2022.02.23.22271388, ~ (2022)
21. Taquet M, "Incidence, co-occurrence, and evolution of long-COVID features : A 6-month retrospective cohort study of 273, 618 survivors of COVID-19", PLoS Med, 18, pp.e1003773~ (2021)
22. Zhao YM, "Follow-up study of the pulmonary function and related physiological characteristics of COVID-19survivors three months after recovery", EClinicalMedicine, 25, pp.100463~ (2020)
23. Frija-Masson J, "Functional characteristics of patients with SARS-CoV-2 pneumonia at 30|days post-infection", Eur Respir J, 56, pp.2001754~ (2020)
24. Mo X, "Abnormal pulmonary function in COVID-19 patients at time of hospital discharge", Eur Respir J, 55, pp.2001217~ (2020)
25. van den Borst B, "Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019(COVID-19)", Clin Infect Dis, 73, pp.e1089~e1098 (2021)
26. Bao C, "Coronavirus disease 2019(COVID-19)CT findings : a systematic review and meta-analysis", J Am Coll Radiol, 17, pp.701~709 (2020)
27. Zhu J, "CT imaging features of 4121 patients with COVID-19 : a meta-analysis", J Med Virol, 92, pp.891~902 (2020)
28. Ramos-Casals M, "Systemic and organ-specific immune-related manifestations of COVID-19", Nat Rev Rheumatol, 17, pp.315~332 (2021)
29. Patell R, "Postdischarge thrombosis and hemorrhage in patients with COVID-19", Blood, 136, pp.1342~1346 (2020)
30. Roberts LN, "Postdischarge venous thromboembolism following hospital admission with COVID-19", Blood, 136, pp.1347~1350 (2020)
31. Wu C, "Prevalence of venous thromboembolism in critically ill patients with coronavirus disease 2019: a meta-analysis", Front Med(Lausanne), 8, pp.603558~ (2021)
32. Puig-Domingo M, "COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology", Endocrine, 72, pp.301~316 (2021)
33. Isidori AM, "COVID-19 infection and glucocorticoids : update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency", J Endocrinol Invest, 43, pp.1141~1147 (2020)
34. Carosi G, "Adrenal insufficiency at the time of COVID-19 : a retrospective study in patients referring to a tertiary center", J Clin Endocrinol Metab, 106, pp.e1354~e1361 (2021)
35. Rubino F, "New-onset diabetes in Covid-19", N Engl J Med, 383, pp.789~790 (2020)
36. di Filippo L, "Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients", Endocrine, 71, pp.9~13 (2021)
37. Hutchings N, "Patients hospitalized with COVID-19have low levels of 25-hydroxyvitamin D", Endocrine, 71, pp.267~269 (2021)
38. Muller I, "SARS-CoV-2-related atypical thyroiditis", Lancet Diabetes Endocrinol, 8, pp.739~741 (2020)
39. Brancatella A, "Subacute thyroiditis after Sars-COV-2infection", J Clin Endocrinol Metab, 105, pp.dgaa276~ (2020)
40. Taquet M, "6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19 : a retrospective cohort study using electronic health records", Lancet Psychiatry, 8, pp.416~427 (2021)
41. Liu YH, "One-year trajectory of cognitive changes in older survivors of COVID-19in Wuhan, China : a longitudinal cohort study", JAMA Neurol, 79, pp.509~517 (2022)
42. Cicco Sebastiano, "Long-Term Follow-Up May be Useful in Coronavirus Disease 2019 Survivors to Prevent Chronic Complications", Infection and Chemotherapy, 52(3), pp.407~409 (2020), 대한감염학회[DOI]
43. Huang L, "1-year outcomes in hospital survivors with COVID-19 : a longitudinal cohort study", Lancet, 398, pp.747~758 (2021)
44. Sivan M, "NICE guideline on long covid", BMJ, 371, pp.m4938~ (2020)
45. Sisó-Almirall A, "Long Covid-19 : proposed primary care clinical guidelines for diagnosis and disease management", Int J Environ Res Public Health, 18, pp.4350~ (2021)
46. Qin W, "Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up", Eur Respir J, 58, pp.2003677~ (2021)
47. Huang C, "6-month consequences of COVID-19 in patients discharged from hospital : a cohort study", Lancet, 397, pp.220~232 (2021)
48. Mallia P, "Symptomatic, biochemical and radiographic recovery in patients with COVID-19", BMJ Open Respir Res, 8, pp.e000908~ (2021)
49. D’Cruz RF, "Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia", ERJ Open Res, 7, pp.00655~02020 (2021)
50. Arnold DT, "Patient outcomes after hospitalisation with COVID-19 and implications for follow-up : results from a prospective UK cohort", Thorax, 76, pp.399~401 (2021)
51. Froidure A, "Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae", Respir Med, 181, pp.106383~ (2021)
52. Sanchez-Ramirez DC, "Long-term impact of COVID-19 : a systematic review of the literature and meta-analysis", Biomedicines, 9, pp.900~ (2021)
53. Raman B, "Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge", EClinicalMedicine, 31, pp.100683~ (2021)
54. Song WJ, "Confronting COVID-19-associated cough and the post-COVID syndrome : role of viral neurotropism, neuroinflammation, and neuroimmune responses", Lancet Respir Med, 9, pp.533~544 (2021)
55. Lewek J, "COVID-19 and cardiovascular complications-preliminary results of the LATE-COVID study", Arch Med Sci, 17, pp.818~822 (2021)
56. Tudoran C, "Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2", Biology(Basel), 10, pp.469~ (2021)
57. Hayama H, "Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019", Glob Health Med, 3, pp.95~101 (2021)
58. Sonnweber T, "Cardiopulmonary recovery after COVID-19 : an observational prospective multicentre trial", Eur Respir J, 57, pp.2003481~ (2021)
59. Małek ŁA, "Cardiac involvement in consecutive elite athletes recovered from Covid-19 : a magnetic resonance study", J Magn Reson Imaging, 53, pp.1723~1729 (2021)
60. Pan C, "Cardiac T1 and T2 mapping showed myocardial involvement in recovered COVID-19 patients initially considered devoid of cardiac damage", J Magn Reson Imaging, 54, pp.421~428 (2021)
61. Joy G, "Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers", JACC Cardiovasc Imaging, 14, pp.2155~2166 (2021)
62. Tenforde MW, "Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States, March-June 2020", MMWR Morb Mortal Wkly Rep, 69, pp.993~998 (2020)
63. Daher A, "Follow up of patients with severe coronavirus disease 2019(COVID-19) : Pulmonary and extrapulmonary disease sequelae", Respir Med, 174, pp.106197~ (2020)
64. Rosales-Castillo A, "Persistent symptoms after acute COVID-19infection: importance of follow-up", Med Clin(Engl Ed), 156, pp.35~36 (2021)
65. Carfì A, "Persistent symptoms in patients after acute COVID-19", JAMA, 324, pp.603~605 (2020)
66. Mandal S, "‘Long-COVID’ : a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19", Thorax, 76, pp.396~398 (2021)
67. Garrigues E, "Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19", J Infect, 81, pp.e4~e6 (2020)
68. Rimmer A, "Covid-19: impact of long term symptoms will be profound, warns BMA", BMJ, 370, pp.m3218~ (2020)
69. Greenhalgh T, "Management of post-acute covid-19 in primary care", BMJ, 370, pp.m3026~ (2020)
70. 정규인, "피로와 우울. 불안증 환자에서 Fatigue Severity Scale의 임상적 유용성", 정신신체의학, 9(2), pp.164~173 (2001), 한국정신신체의학회
71. Townsend L, "Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection", PLoS One, 15, pp.e0240784~ (2020)
72. Alrubaye R, "Severe Rhabdomyolysis in a 35-year-old woman with COVID-19 due to SARSCoV-2 infection : a case report", Am J Case Rep, 21, pp.e926733~ (2020)
73. Chan KH, "Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019(COVID-19)", Am J Emerg Med, 38, pp.1548~ (2020)
74. Husain R, "Rhabdomyolysis as a manifestation of a severe case of COVID-19 : a case report", Radiol Case Rep, 15, pp.1633~1637 (2020)
75. Khosla SG, "Rhabdomyolysis in patients hospitalized with COVID-19 infection : five case series", J Investig Med High Impact Case Rep, 8, pp.2324709620984603~ (2020)
76. Sneller MC, "A longitudinal study of COVID-19 sequelae and immunity : baseline findings", Ann Intern Med, 175, pp.969~979 (2022)
77. Dos Santos PK, "The musculoskeletal involvement after mild to moderate COVID-19 infection", Front Physiol, 13, pp.813924~ (2022)
78. Martelletti P, "Long-COVID headache", SN Compr Clin Med, 3, pp.1704~1706 (2021)
79. Premraj L, "Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome : a meta-analysis", J Neurol Sci, 434, pp.120162~ (2022)
80. Bolay H, "COVID-19 is a real headache!", Headache, 60, pp.1415~1421 (2020)
81. Diaz-Mitoma F, "Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches", Lancet, 1, pp.411~415 (1987)
82. Rozen TD, "Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence : Lessons from the 1890 Russian", Asiatic flu, 2020, pp.40, 1406~1409
83. Nurek M, "Recommendations for the recognition, diagnosis, and management of long COVID : a Delphi study", Br J Gen Pract, 71, pp.e815~25 (2021)
84. Douaud G, "SARS-CoV-2 is associated with changes in brain structure in UK Biobank", Nature, 604, pp.697~707 (2022)
85. Guedj E, "18F-FDG brain PET hypometabolism in patients with long COVID", Eur J Nucl Med Mol Imaging, 48, pp.2823~2833 (2021)
86. Becker JH, "Assessment of cognitive function in patients after COVID-19 infection", JAMA Netw Open, 4, pp.e2130645~ (2021)
87. "British Thoracic Society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia"[URL]
88. "National commissioning guidance for post COVID services"[URL]
89. Bonazza F, "Psychological outcomes after hospitalization for COVID-19 : data from a multidisciplinary follow-up screening program for recovered patients", Res Psychother, 23, pp.491~ (2021)
90. Dong F, "A living systematic review of the psychological problems in people suffering from COVID-19", J Affect Disord, 292, pp.172~188 (2021)
91. "Living guidance for clinical management of COVID-19"[URL]
92. Li L, "Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019(COVID-19)infection", JAMA Netw Open, 3, pp.e2023282~ (2020)
93. Bourne RS, "Sleep disruption in critically ill patients--pharmacological considerations", Anaesthesia, 59, pp.374~384 (2004)
94. Hosey MM, "Survivorship after COVID-19 ICU stay", Nat Rev Dis Primers, 6, pp.60~ (2020)
95. Guedj E, "The impact of COVID-19lockdown on brain metabolism", Hum Brain Mapp, 43, pp.593~597 (2022)
96. "COVID-19 treatment guidelines panel. Coronavirus disease 2019(COVID-19) treatment guidelines"[URL]
97. Ramacciotti E, "Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19(MICHELLE) : an open-label, multicentre, randomised, controlled trial", Lancet, 399, pp.50~59 (2022)
98. Reina-Gutiérrez S, "Effectiveness of pulmonary rehabilitation in interstitial lung disease, including coronavirus diseases : a systematic review and meta-analysis", Arch Phys Med Rehabil, 102, pp.1989~1997 (2021)
99. Liu K, "Respiratory rehabilitation in elderly patients with COVID-19 : A randomized controlled study", Complement Ther Clin Pract, 39, pp.101166~ (2020)
100. Hermann M, "Feasibility and efficacy of cardiopulmonary rehabilitation after COVID-19", Am J Phys Med Rehabil, 99, pp.865~869 (2020)
101. Udina C, "Rehabilitation in adult post-COVID-19 patients in post-acute care with therapeutic exercise", J Frailty Aging, 10, pp.297~300 (2021)
102. Hameed F, "Outcomes of a COVID-19recovery program for patients hospitalized with SARS-CoV-2 infection in New York City : a prospective cohort study", PM R, 13, pp.609~617 (2021)
103. "Rehabilitation guide for patients with COVID-19 related illness"[URL]
104. Myall KJ, "Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment", Ann Am Thorac Soc, 18, pp.799~806 (2021)
105. Denneny EK, "A role for steroids in COVID-19-associated pneumonitis at six-week follow-up?", Ann Am Thorac Soc, 18, pp.1082~1083 (2021)
106. Glynne P, "Long COVID following mild SARS-CoV-2 infection : characteristic T cell alterations and response to antihistamines", J Investig Med, 70, pp.61~67 (2022)
107. Malaty J, "Smell and taste disorders in primary care", Am Fam Physician, 88, pp.852~859 (2013)
108. Xydakis MS, "Post-viral effects of COVID-19 in the olfactory system and their implications", Lancet Neurol, 20, pp.753~761 (2021)
109. Addison AB, "Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction", J Allergy Clin Immunol, 147, pp.1704~1719 (2021)
110. Abdelalim AA, "Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients : a randomized controlled trial", Am J Otolaryngol, 42, pp.102884~ (2021)
111. Damm M, "Olfactory training is helpful in postinfectious olfactory loss : a randomized, controlled, multicenter study", Laryngoscope, 124, pp.826~831 (2014)
112. Hura N, "Treatment of post-viral olfactory dysfunction : an evidence-based review with recommendations", Int Forum Allergy Rhinol, 10, pp.1065~1086 (2020)
113. 박도양, "후각장애 환자에서의 향의 종류, 선호도에 따른 후각훈련의효과 차이", Journal of Rhinology, 26(2), pp.92~98 (2019), 대한비과학회[DOI]
114. Smith ME, "Treatment of myalgic encephalomyelitis", chronic fatigue syndrome : a systematic review for a National Institutes of Health pathways to prevention workshop, 2015, pp.162, 841~850
115. Fowler-Davis S, "A mixed-methods systematic review of post-viral fatigue interventions : are there lessons for long Covid", PLoS One, 16, pp.e0259533~ (2021)
116. Membrilla JA, "Persistent headache after COVID-19 : Pathophysioloy, clinic and treatment", Neurology Perspectives, 1, pp.S31~S36 (2021)
117. MaassenVanDenBrink A, "Headache medication and the COVID-19 pandemic", J Headache Pain, 21, pp.38~ (2020)
118. Kim BS, "Clinical practice guideline of pharmacologic treatment for migraine prevention in adults 2021 : The committee of clinical practice guideline of the Korean Headache Society", Korean J Headache, 21, pp.56~66 (2021)
119. Crook H, "Long covid-mechanisms, risk factors, and management", BMJ, 374, pp.n1648~ (2021)
120. "Chemo brain"[URL]
121. Theoharides TC, "Long-COVID syndrome-associated brain fog and chemofog : Luteolin to the rescue", Biofactors, 47, pp.232~241 (2021)
122. Mazza MG, "Rapid response to selective serotonin reuptake inhibitors in post-COVID depression", Eur Neuropsychopharmacol, 54, pp.1~6 (2022)
123. Nobile B, "The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences of SARS-CoV-2 infection", Front Pharmacol, 12, pp.615695~ (2021)
124. Khani E, "Fluvoxamine and long COVID-19; a new role for sigma-1 receptor(S1R)agonists", Mol Psychiatry (2022)
125. Seo Hyeonji, "Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial", Infection and Chemotherapy, 54(1), pp.102~113 (2022), 대한감염학회[DOI]
126. Sookaromdee Pathum, "Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19", Infection and Chemotherapy, 54(2), pp.369~369 (2022), 대한감염학회[DOI]
127. Hashimoto Y, "Old drug fluvoxamine, new hope for COVID-19", Eur Arch Psychiatry Clin Neurosci, 272, pp.161~163 (2022)
128. Lionetto L, "Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2 : An observational cohort study", Biochim Biophys Acta Mol Basis Dis, 1867, pp.166042~ (2021)
129. Thomas T, "COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status", JCI Insight, 5, pp.e140327~ (2020)
130. Eroğlu İ, "Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019(COVID-19)", Nutrition, 90, pp.111308~ (2021)
131. Castanares-Zapatero D, "Pathophysiology and mechanism of long COVID : a comprehensive review", Ann Med, 54, pp.1473~1487 (2022)
132. Maamar M, "Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers : a cross-sectional study", Curr Med Res Opin, 38, pp.901~909 (2022)
133. Agarwala SR, "Avascular necrosis as a part of ‘long COVID-19’", BMJ Case Rep, 14, pp.e242101~ (2021)
134. Bhanuprasad K, "Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic", Int J Infect Dis, 111, pp.267~270 (2021)
135. Bossley CJ, "Post-acute COVID-19 outcomes in children requiring hospitalisation", Sci Rep, 12, pp.8208~ (2022)
136. Buonsenso D, "FIMP-Roma. Post-COVID condition in adults and children living in the same household in Italy: a prospective cohort study using the ISARIC global follow-up protocol", Front Pediatr, 10, pp.834875~ (2022)
137. Kikkenborg Berg S, "Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls(LongCOVIDKidsDK) : a national, cross-sectional study", Lancet Child Adolesc Health, 6, pp.240~248 (2022)
138. Stephenson T, "Physical and mental health 3 months after SARS-CoV-2 infection(long COVID)among adolescents in England(CLoCk) : a national matched cohort study", Lancet Child Adolesc Health, 6, pp.230~239 (2022)
139. Rimes KA, "Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents : a prospective community study", Pediatrics, 119, pp.e603~e609 (2007)
140. Borch L, "Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study", Eur J Pediatr, 181, pp.1597~1607 (2022)
141. Kuodi P, "Association between BNT162b2 vaccination and reported incidence of post-COVID-19symptoms : cross-sectional study 2020-21, Israel", NPJ Vaccines, 7, pp.101~ (2022)

관련 논문AI추천